New analyst reports spotlight Oracle's cloud momentum, strategic partnerships and expected fiscal 2026 sales growth.

The pharma and biotech CRM software market presents key growth opportunities in AI-driven CRMs and cloud-based solutions, particularly for SMEs, pharma industries, and emerging markets like Asia ...

Oracle’s stock has come well off its highs, but a Jefferies analyst says concentration and debt concerns are overblown.

Oracle stock dropped -29% in the previous month. You may feel inclined to increase your investment, or you might consider decreasing your exposure.

The Department of Health and Social Care publishes its accounting officer assessment of the NHS Electronic Staff Record ...

Finance operations platform BILL and ERP vendor NetSuite have souped up accounts payable capabilities via Agentic AI, ...

Michael Burry, the investor known for his prescient bet against the housing market in 2008, is now turning his attention to ...

Oracle (NYSE: ORCL) is expected to report its second-quarter fiscal 2026 earnings on Dec. 8. It's a tough encore to the tech ...

Investment firms for the world’s ultra-wealthy diverged over their stance on Oracle Corp. during a period when the US ...

A prominent technology analyst has slammed Oracle Corp.'s (NYSE:ORCL) high-profile AI strategy, labeling it “bad behavior” ...

Michael Burry shut down his hedge fund shortly after disclosing his massive short position. Is he already bracing for a crash ...

Discover why Advanced Micro Devices is a Strong Buy. Click to learn about growth from AI deals, future revenue potential, and ...